Genomic/JJ
organization/NN
,/,
sequence/NN
,/,
and/CC
transcriptional/JJ
regulation/NN
of/IN
the/DT
human/JJ
eotaxin/NN
gene/NN
./.

Eotaxin/NN
is/VBZ
an/DT
eosinophil/NN
specific/JJ
beta-chemokine/NN
assumed/VBN
to/TO
be/VB
involved/VBN
in/IN
eosinophilic/JJ
inflammatory/JJ
diseases/NNS
such/JJ
as/IN
atopic/JJ
dermatitis/NN
,/,
allergic/JJ
rhinitis/NN
,/,
asthma/NN
and/CC
parasitic/JJ
infections/NNS
./.
=====
Its/PRP$
expression/NN
is/VBZ
stimulus-/NN
and/CC
cell-specific/JJ
./.
=====
We/PRP
here/RB
describe/VBP
the/DT
genomic/JJ
organisation/NN
(/(
3/CD
exons/NNS
of/IN
132/CD
,/,
112/CD
and/CC
542/CD
bp/NN
and/CC
2/CD
introns/NNS
of/IN
1211/CD
and/CC
378/CD
bp/NN
)/)
and/CC
sequence/NN
including/VBG
3/CD
kb/NN
of/IN
DNA/NN
from/IN
the/DT
immediate/JJ
5'/JJ
upstream/JJ
region/NN
of/IN
the/DT
human/JJ
eotaxin/NN
gene/NN
./.
=====
Among/IN
the/DT
regulatory/JJ
promoter/NN
elements/NNS
potentially/RB
regulating/VBG
eotaxin/NN
gene/NN
expression/NN
and/or/CC
mediating/VBG
the/DT
effects/NNS
of/IN
anti-inflammatory/JJ
drugs/NNS
we/PRP
identified/VBD
consensus/NN
sequences/NNS
known/VBN
to/TO
interact/VB
with/IN
nuclear/JJ
factors/NNS
like/IN
NF-IL6/NN
,/,
AP-1/NN
,/,
a/DT
NF-kappa-B/NN
like/JJ
consensus/NN
sequence/NN
and/CC
gamma-interferon-/NN
as/RB
well/RB
as/IN
glucocorticoid/NN
response/NN
elements/NNS
./.